Name: Engagement in Research 101: Introduction to Engaging Patient & Community Partners in Research
Start: 2025-04-02T10:00:00-04:00
End: 2025-04-02T12:00:00-04:00

UNC Health and UNC School of Medicine

Left to right, Eben Lichtman, MD, and Gianpietro Dotti, MD, have identified a potential way to use CAR T-cells to target a subtype of acute myeloid leukemia.

At the 60th American Society of Hematology Annual Meeting in San Diego on Dec. 3, Eben Lichtman, MD, presented preliminary findings from preclinical studies of CAR T-cells directed towards a potential target called B7-H3, which is found on the cell surface of certain types of AML.

A team led by UNC Lineberger’s Gianpietro Dotti, MD, has engineered immune cells to hunt glioblastoma, the most lethal primary brain tumor.

Tag: Immunotherapy

Researchers identify experimental immunotherapy approach to target acute myeloid leukemia

Researchers identify molecular target for brain cancer, develop immunotherapy approach to attack it